Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05199272
Title A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors 23andMe, Inc.
Indications
Therapies
Age Groups: child | adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Stanford Cancer Institute Palo Alto California 94304 United States Details
Emory University Atlanta Georgia 30322 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
R.J.Zuckerberg Cancer Center Lake Success New York 11042 United States Details
Cohen Children's Medical Center New Hyde Park New York 11040 United States Details
Oregon Health & Science University Portland Oregon 97239 United States Details
Vanderbilt University Nashville Tennessee 37232 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
START Center for Cancer Care San Antonio Texas 78229 United States Details
Virginia Cancer Specialists Fairfax Virginia 22031 United States Details
Ottawa Hospital Cancer Centre Ottawa Ontario K1H 8L6 Canada Details
Princess Margaret Cancer Centre Toronto Ontario M5G 2M9 Canada Details
The Hospital for Sick Children Toronto Ontario M5G1X8 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field